Stocks
EyePoint, Inc.EYPT
NASDAQManufacturingBiotechnology$0.40
Price as of · delayed, not real-time
A manufacturing firm specializing in ophthalmic drug delivery systems, EyePoint develops sustained-release therapies for eye diseases. Its lead products target conditions like diabetic macular edema and wet AMD, and investors track the company for its clinical pipeline and commercial partnerships.
52W Range: $0.39-$19.11
Congressional Interest in EyePoint, Inc. (EYPT)
No congressional trades have been disclosed for EyePoint, Inc. (EYPT) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading EYPT?
No congressional trades found for this stock.